Their results suggest that ADAMTS2 plays a key role in modulating the expression of other heart failure-related genes (including natriuretic peptide A (Nppa) and natriuretic peptide B (Nppb)) in response to isoproterenol treatment. This evidence concerns the gene ADAMTS2 and heart failure.